Related Experiment Video
Updated: Sep 15, 2025
08:17
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
21.3K
Frailty Assessment and NK Cell Function in Multiple Myeloma: a Comprehensive Analysis
Clinical Laboratory
|July 15, 2025
Summary
Natural killer (NK) cells in multiple myeloma (MM) patients show altered numbers and impaired function, with decreased receptor expression correlating with frailty progression. These findings aid in assessing patient health and personalizing treatment.
Area of Science:
- Immunology
- Hematology
- Gerontology
Background:
- Frailty is a common syndrome in multiple myeloma (MM) patients, impacting their quality of life.
- It involves decreased muscle strength, endurance, and multi-system dysfunction.
Purpose of the Study:
- To investigate changes in Natural Killer (NK) cell-related markers in MM patients.
- To explore the correlation between NK cell markers, disease progression (R-ISS stages), and frailty scores.
Main Methods:
- Ten-color flow cytometry was used to analyze NK cell markers.
- 21 MM patients and 16 healthy controls were recruited.
- Data was analyzed based on R-ISS stages and frailty scores.
Main Results:
- MM patients had a higher total NK cell count but impaired function compared to controls.
- Activated NK cell receptor expression decreased as MM progressed and frailty worsened.
- NK cell marker distribution varied across different frailty assessment systems.
Conclusions:
- MM patients exhibit altered NK cell numbers and subpopulations.
- Expression of NK cell receptors (CD244, CD16, HLA-DR) decreases with increasing frailty.
- These immune changes offer insights into patient health and can guide personalized treatment strategies.
